Traumatic Brain Injury (TBI) | Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury
Traumatic Brain Injury (TBI) research study
What is the primary objective of this study?
The primary objective is to assess the long-term impact of hormonal deficiency on Quality of
Life (QoL) in a large group of moderate and severe Traumatic Brain Injury (TBI) patients.
Who is eligible to participate?
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Traumatic Brain Injury (TBI)
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Other:MRI scan and endocrinology analysisEndocrinology analysis including statique and dynamic exams, neuropsychologic evaluations and IRM scan.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Patients With Traumatic Brain InjuryStudy of the association between quality of life and MRI scans and endocrinology analysis (quantification of Growth Hormone) 18 months post-trauma.
Start Date: November 2011
Completed Date: December 2017
Primary Outcome: Evolution of the SF-36(Short-Form health survey)score up to 18 months post-trauma
Secondary Outcome: QOLIBRI (Quality of Life after Brain Injury) measure #1
Study sponsors, principal investigator, and references
Principal Investigator: Sophie Courtois, MD
Lead Sponsor: Hospices Civils de Lyon